Global Guide RNA Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI08247991

Publication Date:

August 12, 2024

Pages:

116

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

gRNA serves as a critical component in CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology, which enables targeted modification of genes. It is usually combined with specific enzymes (such as Cas9 or other Cas proteins in the CRISPR-Cas system) to form an RNA-protein complex for precise recognition and cutting of specific sequences on the DNA chain.This revolutionary technology has applications across various sectors, including agriculture, healthcare, and research. In agriculture, the use of gRNA in CRISPR-based genome editing has the potential to revolutionize crop improvement by enhancing traits such as yield, resistance to diseases, and nutritional content. The healthcare industry is also witnessing a surge in the adoption of gRNA technology for therapeutic purposes, including the development of novel treatments for genetic disorders and cancers. The versatility of gRNA allows scientists and researchers to precisely target and modify specific genes, opening up possibilities for personalized medicine.
The global Guide RNA market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淕uide RNA Industry Forecast鈥� looks at past sales and reviews total world Guide RNA sales in 2022, providing a comprehensive analysis by region and market sector of projected Guide RNA sales for 2023 through 2029. With Guide RNA sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Guide RNA industry.
This Insight Report provides a comprehensive analysis of the global Guide RNA landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Guide RNA portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Guide RNA market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Guide RNA and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Guide RNA.
United States market for Guide RNA is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Guide RNA is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Guide RNA is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Guide RNA players cover Thermo Fisher Scientific, Agilent Technologies, System Biosciences, Jena Bioscience GmbH, Merck KGaA, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Guide RNA market by product type, application, key players and key regions and countries.
Segmentation by Type:
sgRNA
Guide RNA in RNA Editing
Others
Segmentation by Application:
Bioengineering
Medicine
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
sgRNA
Guide RNA in RNA Editing
Others
Segmentation by Application:
Bioengineering
Medicine
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Agilent Technologies
System Biosciences
Jena Bioscience GmbH
Merck KGaA
Azenta
Takara Bio
Synbio Technologies
Revvity
Synthego Corporation
GenScript Biotech Corporation
Omicsbio
SBS Genetech

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Guide RNA Market Size 2019-2030
2.1.2 Guide RNA Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Guide RNA by Country/Region, 2019, 2023 & 2030
2.2 Guide RNA Segment by Type
2.2.1 sgRNA
2.2.2 Guide RNA in RNA Editing
2.2.3 Others
2.3 Guide RNA Market Size by Type
2.3.1 Guide RNA Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Guide RNA Market Size Market Share by Type (2019-2024)
2.4 Guide RNA Segment by Application
2.4.1 Bioengineering
2.4.2 Medicine
2.4.3 Others
2.5 Guide RNA Market Size by Application
2.5.1 Guide RNA Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Guide RNA Market Size Market Share by Application (2019-2024)
3 Guide RNA Market Size by Player
3.1 Guide RNA Market Size Market Share by Player
3.1.1 Global Guide RNA Revenue by Player (2019-2024)
3.1.2 Global Guide RNA Revenue Market Share by Player (2019-2024)
3.2 Global Guide RNA Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Guide RNA by Region
4.1 Guide RNA Market Size by Region (2019-2024)
4.2 Global Guide RNA Annual Revenue by Country/Region (2019-2024)
4.3 Americas Guide RNA Market Size Growth (2019-2024)
4.4 APAC Guide RNA Market Size Growth (2019-2024)
4.5 Europe Guide RNA Market Size Growth (2019-2024)
4.6 Middle East & Africa Guide RNA Market Size Growth (2019-2024)
5 Americas
5.1 Americas Guide RNA Market Size by Country (2019-2024)
5.2 Americas Guide RNA Market Size by Type (2019-2024)
5.3 Americas Guide RNA Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Guide RNA Market Size by Region (2019-2024)
6.2 APAC Guide RNA Market Size by Type (2019-2024)
6.3 APAC Guide RNA Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Guide RNA Market Size by Country (2019-2024)
7.2 Europe Guide RNA Market Size by Type (2019-2024)
7.3 Europe Guide RNA Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Guide RNA by Region (2019-2024)
8.2 Middle East & Africa Guide RNA Market Size by Type (2019-2024)
8.3 Middle East & Africa Guide RNA Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Guide RNA Market Forecast
10.1 Global Guide RNA Forecast by Region (2025-2030)
10.1.1 Global Guide RNA Forecast by Region (2025-2030)
10.1.2 Americas Guide RNA Forecast
10.1.3 APAC Guide RNA Forecast
10.1.4 Europe Guide RNA Forecast
10.1.5 Middle East & Africa Guide RNA Forecast
10.2 Americas Guide RNA Forecast by Country (2025-2030)
10.2.1 United States Market Guide RNA Forecast
10.2.2 Canada Market Guide RNA Forecast
10.2.3 Mexico Market Guide RNA Forecast
10.2.4 Brazil Market Guide RNA Forecast
10.3 APAC Guide RNA Forecast by Region (2025-2030)
10.3.1 China Guide RNA Market Forecast
10.3.2 Japan Market Guide RNA Forecast
10.3.3 Korea Market Guide RNA Forecast
10.3.4 Southeast Asia Market Guide RNA Forecast
10.3.5 India Market Guide RNA Forecast
10.3.6 Australia Market Guide RNA Forecast
10.4 Europe Guide RNA Forecast by Country (2025-2030)
10.4.1 Germany Market Guide RNA Forecast
10.4.2 France Market Guide RNA Forecast
10.4.3 UK Market Guide RNA Forecast
10.4.4 Italy Market Guide RNA Forecast
10.4.5 Russia Market Guide RNA Forecast
10.5 Middle East & Africa Guide RNA Forecast by Region (2025-2030)
10.5.1 Egypt Market Guide RNA Forecast
10.5.2 South Africa Market Guide RNA Forecast
10.5.3 Israel Market Guide RNA Forecast
10.5.4 Turkey Market Guide RNA Forecast
10.6 Global Guide RNA Forecast by Type (2025-2030)
10.7 Global Guide RNA Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Guide RNA Forecast
11 Key Players Analysis
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Information
11.1.2 Thermo Fisher Scientific Guide RNA Product Offered
11.1.3 Thermo Fisher Scientific Guide RNA Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Thermo Fisher Scientific Main Business Overview
11.1.5 Thermo Fisher Scientific Latest Developments
11.2 Agilent Technologies
11.2.1 Agilent Technologies Company Information
11.2.2 Agilent Technologies Guide RNA Product Offered
11.2.3 Agilent Technologies Guide RNA Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Agilent Technologies Main Business Overview
11.2.5 Agilent Technologies Latest Developments
11.3 System Biosciences
11.3.1 System Biosciences Company Information
11.3.2 System Biosciences Guide RNA Product Offered
11.3.3 System Biosciences Guide RNA Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 System Biosciences Main Business Overview
11.3.5 System Biosciences Latest Developments
11.4 Jena Bioscience GmbH
11.4.1 Jena Bioscience GmbH Company Information
11.4.2 Jena Bioscience GmbH Guide RNA Product Offered
11.4.3 Jena Bioscience GmbH Guide RNA Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Jena Bioscience GmbH Main Business Overview
11.4.5 Jena Bioscience GmbH Latest Developments
11.5 Merck KGaA
11.5.1 Merck KGaA Company Information
11.5.2 Merck KGaA Guide RNA Product Offered
11.5.3 Merck KGaA Guide RNA Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Merck KGaA Main Business Overview
11.5.5 Merck KGaA Latest Developments
11.6 Azenta
11.6.1 Azenta Company Information
11.6.2 Azenta Guide RNA Product Offered
11.6.3 Azenta Guide RNA Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Azenta Main Business Overview
11.6.5 Azenta Latest Developments
11.7 Takara Bio
11.7.1 Takara Bio Company Information
11.7.2 Takara Bio Guide RNA Product Offered
11.7.3 Takara Bio Guide RNA Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Takara Bio Main Business Overview
11.7.5 Takara Bio Latest Developments
11.8 Synbio Technologies
11.8.1 Synbio Technologies Company Information
11.8.2 Synbio Technologies Guide RNA Product Offered
11.8.3 Synbio Technologies Guide RNA Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Synbio Technologies Main Business Overview
11.8.5 Synbio Technologies Latest Developments
11.9 Revvity
11.9.1 Revvity Company Information
11.9.2 Revvity Guide RNA Product Offered
11.9.3 Revvity Guide RNA Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Revvity Main Business Overview
11.9.5 Revvity Latest Developments
11.10 Synthego Corporation
11.10.1 Synthego Corporation Company Information
11.10.2 Synthego Corporation Guide RNA Product Offered
11.10.3 Synthego Corporation Guide RNA Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Synthego Corporation Main Business Overview
11.10.5 Synthego Corporation Latest Developments
11.11 GenScript Biotech Corporation
11.11.1 GenScript Biotech Corporation Company Information
11.11.2 GenScript Biotech Corporation Guide RNA Product Offered
11.11.3 GenScript Biotech Corporation Guide RNA Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 GenScript Biotech Corporation Main Business Overview
11.11.5 GenScript Biotech Corporation Latest Developments
11.12 Omicsbio
11.12.1 Omicsbio Company Information
11.12.2 Omicsbio Guide RNA Product Offered
11.12.3 Omicsbio Guide RNA Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Omicsbio Main Business Overview
11.12.5 Omicsbio Latest Developments
11.13 SBS Genetech
11.13.1 SBS Genetech Company Information
11.13.2 SBS Genetech Guide RNA Product Offered
11.13.3 SBS Genetech Guide RNA Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 SBS Genetech Main Business Overview
11.13.5 SBS Genetech Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂